“Two years of inaction on drug price transparency is enough. FGA is taking the fight for transparency to federal court to force the Biden administration to follow the law, without exception and without delay,” Tarren Bragdon, President and CEO of FGA, said in the group’s press release.
“The American people deserve to make informed choices with all cards face up. The Biden administration has made that impossible by putting the needs of Big Pharma before the needs of patients,” Bragdon said. “FGA is fighting for transparency that puts people first.”
The pricing transparency regulation was expected to assist in reducing the cost of medical care. The Biden administration’s move has reportedly resulted in a lack of mitigation of a significant increase in the cost of more than 1,200 prescription medications during the years 2021 and 2022.
Stewart Whitson, FGA legal director, spoke to the suit in the group’s press release, saying “Refusing to enforce a rule on the books without following the formal process of withdrawing the rule is a violation of federal law. FGA is taking this fight directly to the federal court to order the implementation and enforcement of this drug price transparency rule.
“There are no excuses left for the Biden administration: Either they are for transparency or against [it]. Since they won’t implement the rule on their own as the law requires, we’re asking the federal court to order them to, delivering the transparency consumers deserve.”
The Department of Health and Human Services did not immediately respond to The Epoch Times’s request for comment.